Dambkowski Carl sold APGE
August 5, 2026 · Form 4 insider transaction
Dambkowski Carl sold 5,500 shares of Apogee Therapeutics, Inc. at $134.17 per share, a transaction worth $737.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,500
Price
$134.17
Total value
$737.9K
InsiderDambkowski Carl
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 5, 2026
Filing dateAugust 7, 2026
Shares owned after168,498
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 22, 2025.